methamphetamine has been researched along with Ventricular Dysfunction, Left in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatia, HS; DeMaria, A; Kahn, AM; Martinez, A; Nishimura, M; Thomas, IC; Vanam, S | 1 |
| Chau, E; Elkayam, U; Ng, TM; Patel, SV; Reddy, PK; Yang, K | 1 |
| Chen, KQ; Qiao, XL; Shi, YY; Wang, LY; Zhang, LJ; Zheng, XZ | 1 |
| Adigopula, S; Borger, R; Dong, F; Kulczycki, M; Lee, C; Neeki, MM; Toy, J | 1 |
| Chung, JH; Hernandez Conte, A; LaBounty, T; Lubin, L; Padilla, C; Ramzy, D; Zeng, Y | 1 |
| Ito, H; Schatz, IJ; Seto, TB; Tay, K; Wijetunga, M; Yeo, KK | 1 |
| Buonocore, M; Caputo, G; Lopez, JE; Schaefer, S; Yeo, K | 1 |
| Charalampidis, D; Lord, KC; Lucchesi, PA; McIlwain, E; Shenouda, SK; Varner, KJ | 1 |
| Ambrose, J; Barua, R; Srikanth, S | 1 |
9 other study(ies) available for methamphetamine and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Systolic dysfunction in patients with methamphetamine use and heart failure with preserved ejection fraction.
Topics: Heart Failure; Humans; Male; Methamphetamine; Prognosis; Retrospective Studies; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Function, Left | 2022 |
Characteristics of Methamphetamine-associated Cardiomyopathy and the Impact of Methamphetamine Use on Cardiac Dysfunction.
Topics: Administration, Intranasal; Adult; Amphetamine-Related Disorders; Cardiomyopathies; Cardiotoxicity; Case-Control Studies; Central Nervous System Stimulants; Echocardiography; Female; Humans; Male; Methamphetamine; Middle Aged; Smoking; Stroke Volume; Ventricular Dysfunction, Left | 2021 |
Findings on 3D speckle tracking echocardiography in asymptomatic methamphetamine abusers.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Echocardiography; Echocardiography, Three-Dimensional; Humans; Male; Methamphetamine; Ventricular Dysfunction, Left; Ventricular Function, Left; Young Adult | 2018 |
Frequency of Methamphetamine Use as a Major Contributor Toward the Severity of Cardiomyopathy in Adults ≤50 Years.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Cardiomyopathies; Female; Heart Failure; Humans; Male; Methamphetamine; Middle Aged; Odds Ratio; Retrospective Studies; Risk Factors; Severity of Illness Index; Stroke Volume; United States; Ventricular Dysfunction, Left; Young Adult | 2016 |
Utilization of "Stand-By" Extracorporeal Membrane Oxygenation in a High-Risk Parturient With Methamphetamine-Associated Cardiomyopathy Undergoing Dilation and Evacuation: A Case Report.
Topics: Abortion, Therapeutic; Adult; Cardiomyopathies; Central Nervous System Stimulants; Diabetes Mellitus, Type 2; Extracorporeal Membrane Oxygenation; Female; Humans; Hypertension; Methamphetamine; Obesity, Morbid; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy, Triplet; Ventricular Dysfunction, Left | 2017 |
A comparison of echocardiographic findings in young adults with cardiomyopathy: with and without a history of methamphetamine abuse.
Topics: Adult; Amphetamine-Related Disorders; Cardiomyopathy, Dilated; Central Nervous System Stimulants; Female; Heart Atria; Heart Failure; Heart Ventricles; Humans; Male; Methamphetamine; Prevalence; Retrospective Studies; Severity of Illness Index; Stroke Volume; Ultrasonography; Ventricular Dysfunction, Left; Ventricular Function, Left | 2009 |
Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance.
Topics: Adult; Cardiomyopathies; Central Nervous System Stimulants; Contrast Media; Electrocardiography; Female; Fibrosis; Gadolinium DTPA; Humans; Magnetic Resonance Imaging, Cine; Methamphetamine; Myocardium; Predictive Value of Tests; Recovery of Function; Severity of Illness Index; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left | 2009 |
Oxidative stress contributes to methamphetamine-induced left ventricular dysfunction.
Topics: Actin Cytoskeleton; Animals; Antioxidants; Cardiac Catheterization; Cyclic N-Oxides; Disease Models, Animal; Male; Methamphetamine; Mitochondrial Proteins; Myocardial Contraction; Myocardium; Oxidative Stress; Rats; Rats, Sprague-Dawley; Spin Labels; Stroke Volume; Time Factors; Tyrosine; Ultrasonography; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling | 2010 |
Methamphetamine-associated acute left ventricular dysfunction: a variant of stress-induced cardiomyopathy.
Topics: Adult; Cardiomyopathies; Diagnosis, Differential; Echocardiography; Electrocardiography; Female; Humans; Methamphetamine; Substance-Related Disorders; Ventricular Dysfunction, Left | 2008 |